Profound Medical Corp.
PROF
$6.15
$0.152.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 561.68% | 520.87% | 251.15% | 0.67% | -79.19% |
| Total Other Revenue | 26.28% | 20.44% | 24.89% | 19.33% | 32.38% |
| Total Revenue | 68.06% | 41.81% | 32.05% | 9.70% | -5.56% |
| Cost of Revenue | 34.02% | 23.06% | 32.17% | 6.85% | -17.19% |
| Gross Profit | 92.21% | 54.49% | 31.96% | 11.79% | 4.89% |
| SG&A Expenses | 38.70% | 24.82% | 35.25% | 17.73% | 8.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.00% | 21.77% | 28.97% | 11.36% | 0.37% |
| Operating Income | -23.77% | -16.74% | -28.21% | -11.76% | -1.83% |
| Income Before Tax | -14.27% | 1.28% | -8.71% | 1.88% | -4.79% |
| Income Tax Expenses | 100.00% | 99.22% | -97.39% | -146.75% | -144.74% |
| Earnings from Continuing Operations | -14.82% | 0.84% | -7.60% | 3.50% | -3.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.82% | 0.84% | -7.60% | 3.50% | -3.13% |
| EBIT | -23.77% | -16.74% | -28.21% | -11.76% | -1.83% |
| EBITDA | -24.74% | -17.11% | -29.10% | -12.21% | -2.59% |
| EPS Basic | 4.40% | 14.86% | 3.73% | 10.95% | 1.80% |
| Normalized Basic EPS | 4.93% | 15.28% | -6.72% | 0.53% | -10.10% |
| EPS Diluted | 4.62% | 15.04% | 3.52% | 10.74% | 1.57% |
| Normalized Diluted EPS | 4.93% | 15.28% | -6.72% | 0.53% | -10.10% |
| Average Basic Shares Outstanding | 18.94% | 16.89% | 12.35% | 9.02% | 5.58% |
| Average Diluted Shares Outstanding | 18.94% | 16.89% | 12.35% | 9.02% | 5.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |